Maitri Enterprises approved its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, at a board meeting held on August 12, 2026. The company also announced several key management appointments and addressed a procedural compliance oversight with the stock exchange.

The board considered the financial results alongside limited review reports. While specific revenue or profit figures were not disclosed in the board outcome letter, the approval marks the completion of the Q1FY27 reporting cycle for the entity. Trading in the company’s securities, which had been closed since July 1, 2026, is scheduled to reopen 48 hours after the declaration of these results.

Key Management Appointments

The board transacted several personnel changes during the meeting to strengthen internal controls and compliance structures:

• Company Secretary: Ms. Rajshree Jain (ICSI Membership No. A80535) was appointed as Company Secretary and Compliance Officer effective August 12, 2026. She brings experience in corporate law, SEBI compliances, and secretarial audits.
• Internal Auditor: CA Bunty Rajkumar Talreja (Membership No. 139683) was appointed as Internal Auditor for FY27 under Section 138 of the Companies Act, 2013.
• Secretarial Auditor: M/s. Nisarg Sharma & Associates was appointed to fill the casual vacancy left by M/s. SJV & Associates. The new firm will conduct the secretarial audit for FY26 until the next Annual General Meeting.

M/s. SJV & Associates resigned from the role of Secretarial Auditor due to the expiry of its Peer Review Certificate, which prevented it from continuing the audit.

Compliance Clarification

In a separate communication dated August 22, 2026, the company clarified an inadvertent omission regarding the separate intimation of Ms. Jain’s appointment under Regulation 30 of the SEBI (LODR) Regulations, 2015. The company stated that while the appointment was disclosed in the Board Meeting Outcome and XBRL filings, the specific regulatory tag for "Change in Management" was missed due to procedural oversight. Management assured that internal compliance mechanisms have been strengthened to prevent such delays in future filings.

Maitri Enterprises Limited reported a standalone net profit of ₹18.80 lakh for the quarter ended June 30, 2026 (Q1FY26), marking a reversal from the net loss of ₹68.35 lakh recorded in the corresponding period of FY25. While the parent company returned to profitability, the group’s consolidated results showed a net loss of ₹46.34 lakh, widening from the consolidated loss of ₹69.68 lakh in Q1FY25.

The company’s revenue from operations fell 15.6% year-on-year to ₹520.42 lakh, down from ₹616.57 lakh in Q1FY25. This decline was primarily attributed to a drop in sales of pharmaceutical goods, which contracted by 43.1% to ₹109.37 lakh. Conversely, the sale of services segment saw a marginal decline of 3.1% to ₹411.05 lakh.

Standalone vs Consolidated Performance

The divergence between standalone and consolidated results highlights operational pressures within the group structure. While the standalone entity managed to reduce its total expenses to ₹495.37 lakh against an income of ₹522.04 lakh, the consolidated entity faced higher costs. Consolidated total expenses rose to ₹558.97 lakh, exceeding total income of ₹520.50 lakh by ₹38.47 lakh before tax.

In the standalone books, cost of materials consumed decreased significantly to ₹454.86 lakh from ₹318.87 lakh in the prior year, but this was offset by a reduction in inventory changes, which swung from a positive contribution of ₹17.30 lakh in Q1FY25 to a negative ₹271.88 lakh in Q1FY26. Other expenses remained relatively stable at ₹166.82 lakh compared to ₹168.34 lakh in the previous year.

What the Numbers Show

A critical divergence exists between the performance of the two operating segments on a consolidated basis. The 'Sale of Services' segment generated a positive segment result of ₹56.71 lakh, maintaining its profitability despite lower revenues. In contrast, the 'Pharmaceutical Goods' segment incurred a significant loss of ₹65.08 lakh, compared to a loss of ₹23.44 lakh in Q1FY25. This deepening loss in the pharmaceutical segment, coupled with unallocated losses of ₹30.10 lakh, drove the overall consolidated pre-tax loss. The data suggests that while the service arm remains resilient, the goods distribution business is facing margin compression or increased working capital costs that are not fully reflected in the top-line revenue decline alone.

Auditor Qualification on Receivables

The consolidated financial results were subject to a qualified review conclusion by the statutory auditors, Dinesh R. Thakkar & Co. The qualification stems from insufficient audit evidence regarding the recoverability of trade receivables amounting to ₹163.63 lakh in the wholly-owned subsidiary, BSA Marketing Private Limited. These balances have been outstanding for over three years out of total trade receivables of ₹241.53 lakh as of June 30, 2026.

Management recognized an impairment loss of ₹62.42 lakh for the quarter based on Expected Credit Loss (ECL) assessments under Ind AS 109. However, auditors could not verify the recoverability of the remaining unimpaired balance, leaving open the possibility of further adjustments to the carrying amount of receivables and the group’s financial results.

Corporate Appointments

During its board meeting held on August 12, 2026, Maitri Enterprises approved several key appointments:

• Internal Auditor: CA Bunty Rajkumar Talreja was appointed for the financial year 2026-27.
• Secretarial Auditor: M/s. Nisarg Sharma & Associates was appointed to fill the casual vacancy left by M/s. SJV & Associates, whose peer review certificate had expired. The new auditor will serve until the conclusion of the ensuing Annual General Meeting.
• Company Secretary: Ms. Rajshree Jain was appointed as Company Secretary and Compliance Officer effective August 12, 2026.

The trading window for dealing in the company’s securities will reopen 48 hours after the declaration of these results.